Posted on 4월 1, 20214/1/21
Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth
Posted on 2월 11, 20212/11/21
Alternative Product Distribution Model: Where Agility Meets Profitability
Posted on 1월 19, 20211/19/21
The 10-Year Test: Is It Possible to Plan Launch During Clinical Development?
Posted on 1월 15, 20211/15/21
Emerging 2021 Life Science Priorities
Posted on 1월 14, 20211/14/21
EVERSANA is Fighting COVID-19 Through a Growing Number of Client Engagements
Posted on 12월 29, 202012/29/20
Leading the Way in Digital Health With Tech-Driven Clinical Pathways
Posted on 12월 17, 202012/17/20
Achieve Price and Access Launch Excellence in a Disrupted World
Posted on 12월 10, 202012/10/20
EVERSANA Receives PM360 Innovations Award for Seamlessly Disrupting Commercialization
Posted on 12월 4, 202012/4/20
A New Pharmaceutical Strategy for Europe
Posted on 12월 2, 202012/2/20